π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The primary purpose of this multi-centre, double blind-study is to evaluate...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01635621
Treatments Being Tested
Olokizumab (OKZ) has been shown to reverse the inhibitory effect of IL-6 on...
Status
Completed
Location
Comac Medical Ltd
Start Date
2021-11-16
Trial ID
NCT04246762
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy and safety ...
Status
Completed
Location
102
Start Date
2011-10
Trial ID
NCT01463059
Treatments Being Tested
The purpose of this study is to evaluate the safety, efficacy, pharmacokine...
Status
Completed
Location
166
Start Date
2010-11
Trial ID
NCT01242488